Global energy balance in mammals is controlled by the actions of circulating hormones that coordinate fuel production and utilization in metabolically active tissues. Bone-derived osteocalcin, in its undercarboxylated, hormonal form, regulates fat deposition and is a potent insulin secretagogue. Here, we show that insulin receptor (IR) signaling in osteoblasts controls osteoblast development and osteocalcin expression by suppressing the Runx2 inhibitor Twist2. Mice lacking IR in osteoblasts have low circulating undercarboxylated osteocalcin and reduced bone acquisition due to decreased bone formation and deficient numbers of osteoblasts. With age, these mice develop marked peripheral adiposity and hyperglycemia accompanied by severe glucose intolerance and insulin resistance. The metabolic abnormalities in these mice are improved by infusion of undercarboxylated osteocalcin. These results indicate the existence of a bone-pancreas endocrine loop through which insulin signaling in the osteoblast ensures osteoblast differentiation and stimulates osteocalcin production, which in turn regulates insulin sensitivity and pancreatic insulin secretion.
INTRODUCTION
Management of constant energy supply in an environment of variable food intake is critical for the survival of all terrestrial species. To this end, mammals have evolved intricate networks of local and circulating factors that coordinate energy expenditure by communicating metabolic information between the major organs that produce, store, and utilize energy. The skeleton is a highly metabolic tissue and is increasingly recognized as an important player in the coordination of global energy utilization through its hormonal interactions with other tissues (Fukumoto and Martin, 2009; Lee and Karsenty, 2008) . As an example, leptin is a well characterized hormone produced by adipocytes that influences insulin sensitivity (Yamauchi et al., 2001 ) and also regulates postnatal bone acquisition (Karsenty, 2006) . It is now appreciated that leptin acts indirectly on bone by activating sympathetic nerves whose efferent outputs target b 2 -adrenergic receptors on osteoblasts to regulate their proliferation and differentiation (Ducy et al., 2000; Takeda et al., 2002) . Upregulation of sympathetic tone by leptin has also been shown to inhibit insulin secretion via a mechanism involving the osteoblast .
Several lines of circumstantial evidence suggest that insulin also impacts bone development and physiology by regulating osteoblast function. First, a functional insulin receptor (IR) is expressed by osteoblasts and exposure of primary osteoblasts or osteoblast-like cell lines to physiological levels of insulin increases bone anabolic markers including collagen synthesis (Pun et al., 1989; Rosen and Luben, 1983) , alkaline phosphatase production (Kream et al., 1985) , and glucose uptake (Ituarte et al., 1989) . Second, patients with Type-1 diabetes mellitus (T1DM) can develop early onset osteopenia or osteoporosis (Kemink et al., 2000; Thrailkill, 2000) , and have an increased risk of fragility fracture (Janghorbani et al., 2006; Nicodemus and Folsom, 2001) , as well as poor bone healing and regeneration after injury (Loder, 1988) . Analogous bone abnormalities are observed in animal models of T1DM that also exhibit bone loss (Herrero et al., 1998; Verhaeghe et al., 1990) due to reduced bone formation (Goodman and Hori, 1984; Shires et al., 1981; Verhaeghe et al., 1992; Verhaeghe et al., 1990) . Localized insulin delivery accelerates healing in these models by enhancing osteogenesis (Gandhi et al., 2005) . For the hormonal networks described above to function effectively, it is reasonable to suggest that signals emanating from the osteoblast should regulate the action of both insulin and leptin. Osteocalcin, a factor produced only by osteoblasts (Weinreb et al., 1990) , is a good candidate to fulfill such a function (Lee et al., 2007) . Similar to other hormones, osteocalcin is synthesized as pre-pro-osteocalcin that is processed into pro-osteocalcin in the endoplasmic reticulum. Before being secreted by osteoblasts, osteocalcin undergoes vitamin K-dependent carboxylation on three Gla residues that endows the molecule with high affinity for bone matrix. A small portion of osteocalcin remains undercarboxylated and is secreted into the circulation (Delmas et al., 1983) . The undercarboxylated form of osteocalcin has been proposed to act as a hormone that links bone to other regulators of glucose homeostasis, including insulin and leptin Lee et al., 2007) .
Previous attempts to demonstrate a biological role for insulin in bone have been complicated by the potentially confounding presence of IGF-1R in osteoblasts (Fulzele et al., 2007) , which activates intracellular signaling pathways common to those activated by insulin. To circumvent this problem and to directly examine the function of insulin signaling in bone, we engineered mice lacking IR specifically in osteoblasts (Ob-DIR). Here we show that mutant Ob-DIR mice accumulate less trabecular bone due to a failure of osteoblast maturation and decreased bone formation. With age, the Ob-DIR mice developed marked peripheral adiposity and insulin resistance accompanied by decreased circulating undercarboxylated osteocalcin. These metabolic abnormalities were improved by infusion of exogenous undercarboxylated osteocalcin. Our results suggest the existence of a bone-pancreas endocrine loop through which insulin signaling in the osteoblasts stimulates osteocalcin production, which in turn regulates pancreatic insulin secretion to control glucose homeostasis.
RESULTS

IR Is Required for Osteoblast Proliferation, Survival, and Differentiation
To begin to define specific actions of insulin in bone, we determined the cellular localization of IR in bone from mature wildtype mice. IR immunoreactivity was abundant in osteoblasts on trabecular bone surfaces but was low or absent in osteocytes ( Figure 1A ). We next assessed the requirement of IR for osteoblast proliferation, survival, and differentiation in vitro. Primary osteoblasts were isolated from the calvarial bones of newborn IR floxed mice (Bruning et al., 1998) and infected with adenovirus expressing Cre recombinase to disrupt IR expression (hereafter referred to as DIR) or with adenovirus expressing GFP as a control ( Figure 1B) . DIR osteoblasts had reduced BrdU incorporation ( Figure 1C ) and increased sensitivity to apoptotic signals when examined by Annexin V staining ( Figure 1D ) compared to controls. In addition, differentiation was severely impaired in DIR osteoblasts, which accords with our previous studies that demonstrated that insulin treatment increased markers for osteoblast differentiation (Fulzele et al., 2007) . Alkaline phosphatase and Alizarin Red staining after culture in osteogenic media (consisting of 10% serum that contains insulin, 10 mM b-glycerol phosphate and 50 mg/ml ascorbic acid) were significantly decreased in DIR osteoblasts when compared to controls (Figure 1E) , and these deficiencies were accompanied by decreased expression of Runx2 and osteocalcin mRNA ( Figure 1F ). Exposure of IR-deficient osteoblasts to exogenous IGF-1, which elicits downstream signaling events similar to insulin, did not improve alkaline phosphatase expression or the degree of matrix mineralization in DIR osteoblasts ( Figure 1G ).
Insulin Promotes Osteoblast Differentiation by Suppressing Twist2
The profound defect in differentiation observed in osteoblasts lacking IR suggested that insulin signaling influences the expression or activity of a central regulator of the osteoblast differentiation program. In this regard, Runx2 seemed an obvious candidate because the expression of this factor was decreased in differentiating DIR osteoblasts ( Figure 1F ). Insulin treatment induced a 3-fold increase in osteocalcin promoter activity (Figure 1H ) and a 2.5-fold increase in Runx2 occupancy of the OSE2 element when assessed by quantitative chromatin immunoprecipitation ( Figure 1I ). Further, Runx2 binding to the osteocalcin promoter was decreased in osteoblasts lacking the IR ( Figure 1J ). However, although insulin induced a 6-fold increase in osteocalcin mRNA expression, Runx2 expression was not affected ( Figure 1K ). These data indicated that insulin regulates Runx2 activity via an indirect mechanism.
To identify insulin-sensitive target genes that may influence Runx2 in osteoblasts we profiled RNA isolated from insulin treated DIGF-1R osteoblasts (used to eliminate the possibility of IGF-1R cross-activation by insulin) by microarray (Affymetrix Murine Genome 430-2.0). This analysis revealed 543 genes that were positively and negatively regulated by 4-fold or greater in response to 12 hr of insulin treatment (see Table S1 available online), including 16 genes known to be involved in osteoblast differentiation ( Figure 1L ). Among these, Twist2, an established inhibitor of Runx2 activity (Bialek et al., 2004) , was downregulated. Separate studies in primary osteoblasts confirmed the inhibition of Twist2 as well as Twist1 mRNA after treatment (L) Microarray analysis of insulin-regulated genes 4-fold over-or underexpressed and related to bone remodeling in DIGF-1R osteoblasts as identified by gene ontology analysis (see also Table S1 ). All error bars represent SEM. with insulin ( Figure 1M ). Conversely, disruption of IR upregulated Twist2 and to a lesser extent Twist1 mRNA but did not alter other established regulators of Runx2 activity ( Figure 1N ). Coimmunoprecipitation experiments demonstrated a decrease in Runx2 protein levels and an increase in the fraction of Runx2 bound by Twist2 in cells lacking IR ( Figure 1O ). Taken together, these data suggest that insulin signaling regulates osteoblast differentiation, in part, by suppression of the Runx2 inhibitor Twist2.
Mice Lacking IR in Osteoblasts Have Reduced Postnatal Bone Acquisition
To determine the importance of insulin signaling in bone development in vivo, we analyzed the skeletal phenotype of mice lacking the IR in osteoblasts. Male progeny from matings between OC-Cre TG/+ IR flox/flox and IR flox/flox mice (Bruning et al., 1998) with the genotype OC-Cre TG/+ IR flox/flox (hereafter, referred to as Ob-DIR) were selected for detailed analysis. Allele-specific PCR performed on DNA isolated from tissues of Ob-DIR mice revealed that recombination of IR alleles occurred only in skeletal tissues (i.e., calvaria, femur, and vertebrae) ( Figure 2A ). Male littermates lacking the OC-Cre transgene and, therefore, wildtype for IR gene function served as controls.
The loss of IR in osteoblasts dramatically impaired postnatal trabecular bone acquisition. Whereas control mice accumulated trabecular bone to maximal levels by 6 weeks, mice lacking IR failed to accumulate trabecular bone; trabecular bone volume (BV/TV) was decreased by >47% in Ob-DIR mice compared to controls at both 3 and 6 weeks of age ( Figures 2B and 2C ). This defect in bone acquisition was characterized by significant decreases in trabecular numbers (Tb. N, Figure 2D ) and thickness (Tb. Th, Figure 2E ), and significant increases in trabecular spacing (Tb. Sp, Figure 2F ).
Static and dynamic histomorphometric analyses performed at 3 and 6 weeks of age showed that the decrease in bone volume in Ob-DIR mice was secondary to a reduction in the number of osteoblasts. Osteoblast numbers per bone perimeter (Ob. N/BPM) in Ob-DIR mice were decreased by 79% at 3 weeks of age ( Figure 2G ) and 47% at 6 weeks of age ( Figure 2H ) when compared to controls. This decrease in osteoblast numbers was accompanied by a 30% reduction in bone formation rate (BFR/ BS, 13.46 ± 2.02 versus 9.34 ± 0.92, mean ± standard error of the mean [SEM], p = 0.06) at 6 weeks of age ( Figure 2I ). Osteoclast numbers per bone perimeter (Oc. N/BPM) were unchanged in Ob-DIR mice when compared to controls ( Figure 2J ). However, erosion depth was decreased at 3 weeks of age in Ob-DIR mice ( Figure 2K ), indicating a decrease in osteoclast activity. Consistent with this, the serum levels of CTx were significantly decreased ( Figure 2L ) in Ob-DIR mice and differentiating DIR osteoblasts expressed significantly more Opg than controls ( Figure 2M ). These histomorphometric data contrast to the phenotype of mice lacking the IGF-1R that have increased osteoblast numbers and more bone matrix that is undermineralized (Zhang et al., 2002) . When considered together with our in vitro data, these results suggest that IR is required for normal postnatal bone acquisition, and that the bone phenotype in these mice is likely due to a failure of normal osteoblast differentiation resulting from increased Twist2 expression and a suppression of Runx2.
Mice Lacking IR Develop Increased Adiposity and Insulin Resistance
Ob-DIR mice had normal longitudinal growth but developed an unanticipated increase in total body mass relative to control littermates ( Figures 3A and 3B) . Measurements of body composition at 24 weeks by qMR revealed a 40% increase in fat mass ( Figure 3C ) and an 8% decrease in lean mass in Ob-DIR mice relative to controls ( Figure 3D ). At necropsy the weights of the major fat pads were increased by 12 weeks in Ob-DIR mice ( Figure 3E ) and were further increased at 24 weeks of age ( Figure 3F ). The accumulation of peripheral fat did not result from changes in feeding behavior as food intake, measured at 12 weeks, was similar in control and Ob-DIR mice ( Figure 3G ). Indirect calorimetry demonstrated that Ob-DIR mice had decreased rates of oxygen consumption compared with controls (VO 2 , Figure 3H ), without a change in the respiratory exchange ratio (RER; Figure 3I ). Thus, the decreased rate of oxidative metabolism resulted in overall decreased rates of energy expenditure ( Figure 3J ). By contrast, body weights (Figures 3K and 3L) and composition ( Figures 3M and 3N ) of mice lacking the IGF-1R in osteoblasts were similar to control littermates.
The peripheral adiposity in Ob-DIR mice suggested that the increase in body fat occurred secondary to alterations in glucose homeostasis and/or insulin dynamics. In accordance with this idea, nonfasting serum glucose levels were significantly increased in Ob-DIR mice ( Figure 4A ), whereas serum insulin ( Figure 4B ) was decreased. To assess total body sensitivity to glucose and insulin, we performed standard glucose tolerance test (GTT) and insulin tolerance test (ITT) at both the 12-week and 24-week time points. Baseline, fasting-glucose concentrations were similar in Ob-DIR and control mice. However, glucose excursions in glucose-challenged Ob-DIR mice were significantly higher than controls ( Figures 4C and 4E ). In addition, insulin administration did not lower glucose concentrations to the extent seen in control mice ( Figures 4D and 4F) .
The lower circulating insulin levels in nonfasted Ob-DIR mice, together with their exaggerated glucose excursions (GTT) and insulin insensitivity (ITT), suggested the development of insulin resistance in the face of reduced insulin secretory reserves. In accordance with this scenario, b cell area and mass were decreased at 12 weeks (data not shown) and 24 weeks in Ob-DIR mice when compared to controls ( Figures 4G-4I) , and this was accompanied by reduced expression of Ins1 and Ins2 ( Figure 4J) . Additionally, the expression of gene markers for insulin sensitivity was reduced in white and brown adipose tissue, whereas genes associated with gluconeogenesis were enhanced in the liver (Figures 4K-4O ). Taken together, these results suggest that loss of insulin signaling in osteoblasts results in increased fat accumulation accompanied by both glucose intolerance and target tissue insulin resistance.
Metabolic Dysregulation in Ob-DIR Mice Is Caused by Reduced Undercarboxylated Osteocalcin
The accumulation of peripheral fat, glucose intolerance, and insulin resistance, together with decreased insulin levels in the Ob-DIR mice, are reminiscent of the alterations in serum biochemistry and body composition seen previously in osteocalcindeficient mice (Lee et al., 2007) . Moreover, osteoblast-derived undercarboxylated osteocalcin is a potent secretogogue for insulin (Ferron et al., 2008) . These observations, together with our current demonstration that insulin potently stimulates osteocalcin expression in osteoblasts, suggested the possibility that osteocalcin might function as a circulating factor responsible for the increased fat accumulation and changes in insulin sensitivity in the Ob-DIR mice. To investigate this possibility, we measured total and undercarboxylated osteocalcin in the serum of control and Ob-DIR mice. Total and undercarboxylated osteocalcin serum levels were decreased significantly in the Ob-DIR mice compared to controls (Figures 5A and 5B, respectively). Total and undercarboxylated osteocalcin levels were also lower in conditioned media of DIR osteoblasts than in that of controls ( Figures 5C and 5D , respectively), suggesting that the lower levels of undercarboxylated osteocalcin in Ob-DIR mice were not related to renal clearance (Delmas et al., 1983 ).
To provide additional evidence that osteocalcin deficiency underlies the metabolic disturbances in the Ob-DIR mice, we measured the effect of a two-week infusion of undercarboxylated osteocalcin on glucose and insulin sensitivity measured by GTT and ITT. When infused with undercarboxylated osteocalcin and challenged with glucose, Ob-DIR mice had blunted glucose excursions and more pronounced reductions in serum glucose after a bolus of insulin relative to controls, indicating an improved sensitivity to insulin ( Figures 5E and 5F ). Collectively, these results suggest a model in which insulin signaling in osteoblasts activates transcriptional events that promote osteoblast differentiation and control the production and bioavailability of osteocalcin. The undercarboxylated form of osteocalcin, in turn, acts as a circulating hormone to regulate fat accumulation and insulin production and sensitivity ( Figure 5G ).
DISCUSSION
In this study, we uncovered two previously unappreciated roles for insulin in bone that are both achieved by the ability of the hormone to activate a common osteoblast transcriptional pathway. First, insulin suppresses the Runx2 inhibitor Twist2, which promotes osteoblast differentiation necessary for normal bone formation. Second, insulin induces production of the insulin secretagogue osteocalcin, which influences glucose utilization. These results suggest the existence of a novel endocrine regulatory loop in which insulin signaling in the osteoblast controls postnatal bone development and simultaneously regulates insulin sensitivity and pancreatic insulin secretion to regulate glucose homeostasis.
Insulin Regulates Osteoblast Function and Postnatal Bone Acquisition
The reduced bone mass and osteoblast numbers in the Ob-DIR mice, together with the lower proliferation and differentiation capacity of IR-deficient osteoblasts in vitro, demonstrate that insulin signaling is critical for osteoblast function. This bone phenotype is strikingly different from that observed in mice lacking the IGF-1R in osteoblasts, which exhibit normal or even elevated numbers of mature osteoblasts (Zhang et al., 2002) . Transcriptional profiling and immunoprecipitation experiments conducted in insulin-treated DIGF-1R osteoblasts indicated that insulin signaling regulates osteoblast differentiation by suppression of Twist2, a known inhibitor of Runx2 (Bialek et al., 2004) . Precisely how IR signaling is coupled to transcriptional control of osteoblast function deserves further study. A good candidate is the forkhead protein FoxO1 that is known to be downstream of IR and serves to suppress insulin action in many target tissues (Accili and Arden, 2004; Kitamura et al., 2002; Nakae et al., 2002 Nakae et al., , 2003 . FoxO1 activity is associated with decreased proliferation and increased sensitivity to apoptosis inducing signals (Paik et al., 2007) , a phenotype identical to that observed in osteoblasts lacking IR, which should have increased FoxO1 activity. Unfortunately, firm conclusions regarding potential IR/FoxO1 interactions in bone cannot be made due to the fact that a large percentage of mice lacking FoxO1 in osteoblasts die shortly after birth (Rached et al., 2010) . However, the portion of mice lacking FoxO1 in osteoblasts that survive have increased glucose tolerance and increased insulin sensitivity, metabolic features opposite from the Ob-DIR mice described in this paper.
Our findings of reduced trabecular bone in the Ob-DIR mice contrast to previous reports of normal bone mass in a mouse globally deficient in IR (Irwin et al., 2006) . In these mice, postnatal lethality due to ketoacidosis was genetically rescued by transgenic re-expression of the IR in the pancreas, liver, and brain (tTr-IRKO mice) (Okamoto et al., 2004) . However, because bone volume in these mice was measured at a single time point (6 months) we suspected that changes in bone mass due to loss of the insulin receptor might have been missed, particularly because the changes observed in our Ob-IR-deficient mice were most pronounced at early postnatal time points. Micro-CT measurements in these mice conducted by our laboratory revealed a reduced trabecular bone volume compared to control animals at 3 weeks of age (data not shown). Therefore, the loss of IR in osteoblasts in two mouse models created using different genetic strategies produced a remarkably similar bone phenotype, thus confirming the importance of IR in normal bone acquisition.
In addition to controlling osteocalcin gene transcription, insulin also appears to regulate posttranslational modification of osteocalcin because the proportion of undercarboxylated osteocalcin was decreased in both the conditioned media from IR null differentiated osteoblasts and in serum from Ob-DIR mice. Neither of these events were observed in osteoblasts exposed to IGF-1, clearly indicating that insulin and not IGF-1 is a primary regulator of osteocalcin mRNA expression and possibly posttranslational processing. Also, whereas loss of IGF-1R in osteoblasts could be partially rescued by insulin (Fulzele et al., 2007) , osteoblasts lacking IR were not rescued by IGF-1. Together, these results indicate that signals derived from the IR are even more critical for osteoblast development than those generated by IGF-1 and cannot be compensated by other factors at least during early bone development.
Insulin Stimulates Osteocalcin to Regulate Glucose Homeostasis
The metabolic phenotype in mice lacking IR in their osteoblasts suggests the development of tissue resistance to insulin coupled with deficient insulin secretory reserves, a phenotype virtually identical to that observed in osteocalcin-deficient mice (Lee et al., 2007) . These observations fit with an emerging body of data that implicate circulating undercarboxylated osteocalcin as a bone-derived hormone that helps coordinate glucose homeostasis and body composition (Lee and Karsenty, 2008) . Thus, osteocalcin induces insulin production by pancreatic b cells and adiponectin secretion from adipocytes (Lee et al., 2007) . Moreover, osteocalcin increased basal and insulin stimulated glucose transport in adipocytes (Ferron et al., 2008) . The current study identifies insulin as a critical regulator of osteocalcin production. Levels of osteocalcin were reduced in serum of Ob-DIR knockout mice and medium conditioned by their osteoblasts. Moreover, the observation that infusion of osteocalcin improved glucose tolerance and insulin sensitivity strongly suggests that the metabolic and body composition alterations in the Ob-DIR mice are due to the loss of insulin's ability to stimulate osteocalcin expression in osteoblasts.
The hormonal activity of osteocalcin with respect to its secretion and actions on fat and pancreas appear to be regulated by posttranslational g-carboxylation that we predict is also controlled by insulin. In this regard, the percentage of circulating undercarboxylated osteocalcin was decreased in the Ob-DIR mice. We anticipated that insulin might control g-carboxylation of osteocalcin by regulating osteotesticular protein tyrosine phosphatase (OST-PTP), the product of the Esp gene known to be required for osteocalcin carboxylation (Lee et al., 2007) . Thus, Esp-deficient mice produce more undercarboxylated osteocalcin and exhibit increased insulin secretion, hypoglycemia, and increased insulin sensitivity, whereas overexpression of Esp produces the opposite phenotype. It should be noted, however, that a homolog for the Esp gene has so far not been identified in humans. Therefore, other genes and/or mechanisms, such as vitamin K-dependent g-carboxylase, are likely to play a role in the regulation of osteocalcin g-carboxylation by insulin.
Although additional studies will be required to fully establish the exact physiological relevance of our findings, several existing studies in humans are consistent with the insulin-osteocalcin endocrine loop suggested here. Serum levels of undercarboxylated osteocalcin correlate with improved glucose tolerance in men (Hwang et al., 2009) . Moreover, serum osteocalcin concentrations have been found to be inversely associated with blood markers of dysmetabolic phenotype and measures of adiposity (Pittas et al., 2009 ). On a more fundamental level, our work supports a growing body of data that indicates that the skeleton plays an integrative role in regulating energy expenditure and fuel utilization (Karsenty, 2006) . In summary, the results presented in this paper suggest the existence of a novel bone-pancreas feedback loop through which insulin signaling in the osteoblast promotes postnatal bone acquisition and simultaneously stimulates osteocalcin production, which in turn, regulates pancreatic insulin secretion to control glucose homeostasis. These observations should have immediate impact on our understanding of the global control of energy balance and theoretically guide new approaches for treatment of bone disease and diabetes.
EXPERIMENTAL PROCEDURES Animal Models
All procedures involving mice were approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham and Johns Hopkins University. Mice lacking IR in osteoblasts were generated by crossing osteocalcin-Cre (OC-Cre) transgenic mice (Zhang et al., 2002) with IR flox/flox mice (Bruning et al., 1998) . The following primer pairs that amplify exons 3-5 were used to assess tissue-specific recombination: 5 0 -GCTGCACAGCT GAAGGCCTGT-3 0 and 5 0 -CTCCTCGAATCAGATGTAGCT-3 0 . Ob-DIGF-1R mice have been described previously (Zhang et al., 2002) . Genotyping strategies are available upon request.
Culture of Primary Osteoblasts
Osteoblasts were isolated from calvaria of newborn mice by serial digestion in 1.8 mg/ml of collagenase. For in vitro deletion of the IR and IGF-1R, osteoblasts containing floxed alleles were infected with adenovirus encoding Cre recombinase or green fluorescent protein (Vector Biolabs) as previously described (Fulzele et al., 2007) . Infection with 100 mulitiplicity of infection was used in all experiments. Osteoblast differentiation was induced by supplementing aMEM media with 10% serum (that contains insulin), 10 mM b-glycerol phosphate, and 50 mg/ml ascorbic acid. Alkaline phosphatase and Alizarin Red S staining were carried out according to standard techniques.
Gene Expression Studies
Total RNA was extracted using TriZol, reverse transcribed using iScript cDNA Synthesis Kit (Bio-Rad), and amplified by real-time PCR using SYBR GREEN PCR Master Mix (Bio-Rad 
Imaging and Histomorphometry
Male control and Ob-DIR mice were sacrificed at the indicated age and bone volume in the distal femoral metaphysis was assessed using a desktop microtomographic imaging system (MicroCT40; Scanco Medical). Histological analyses, using a semi-automatic method (Osteoplan II, Kontron) were carried out on 3-and 6-week-old mice injected with 1% calcein (w/v) 3 and 2 days before sacrifice, and 5 and 3 days before sacrifice, respectively (Zhang et al., 2002) . Histomorphometric parameters follow the recommended nomenclature of the American Society of Bone and Mineral Research (Parfitt et al., 1987) . Body composition was measured by DEXA (Lunar PIXImus II GE Healthcare) and qMR (3-in-1 Composition Analyzer, Echo Medical Systems) at 24 weeks of age. Pancreata were fixed and stained, and islet morphometry was performed as previously described (Hussain et al., 2006) . IR expression was examined in mouse long bones using an antibody from Upstate Biotechnology after tissue was fixed in 10% buffered formalin, decalcified in 10% Na2EDTA, paraffin embedded, and then processed for immunostaining according to standard techniques.
Metabolic Studies and Bioassays
For glucose tolerance test, glucose (1.5 g/kg BW) was injected IP after an overnight fast. For insulin tolerance test, mice were fasted for 4 hr and then injected IP with insulin (0.2 U/kg BW). Glucose was measured using a Glucose 201 analyzer (Hemocue, Lake Forest, CA, USA). For serum chemistries, insulin and glucose were measured with the Ektachem DT II System (Johnson & Johnson Clinical Diagnostics). Indirect calorimetry was conducted in a open-flow indirect calorimeter (Oxymax Equal Flow System; Columbus Instruments). Calorimetry, daily body weight and daily food intake data were acquired during a 4 day experimental period. Data from the first 3 days was used to confirm acclimation to the calorimetry chamber, and the fourth day was used for analyses. Rates of oxygen consumption (VO 2 , ml/kg/hr) and carbon dioxide production (VCO 2 ) were measured for each chamber every 8 min throughout the study. Respiratory exchange ratio (RER = VCO 2 /VO 2 ) was calculated by Oxymax software (v. 4.02) to estimate relative oxidation of carbohydrate (RER = 1.0) versus fat (RER approaching 0.7), not accounting for protein oxidation. Energy expenditure was calculated as EE = VO 2 3 (3.815 + (1.232 3 RER)) (Lusk, 1928) , and normalized for subject body mass (kcal/kg/hr). Osteocalcin levels were measured by IRMA assay (Immunotopics). Hydroxyapatite resin, which binds the carboxylated form, was used to assess percentages of carboxylated and undercarboxylated osteocalcin (Lee et al., 2007) . Bacterially produced mouse recombinant undercarboxylated osteocalcin or saline control was infused at 30 ng/g BW/h using Alzet mini-osmotic pumps implanted subcutaneously (Ferron et al., 2008) .
Statistics
All results are presented as means ± standard errors of the mean. Statistical analyses were performed using unpaired, two-tailed Student's t or ANOVA tests followed by post hoc tests. In all figures, * % 0.05.
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